[more]

PEPperPRINT and MalVa announce a joint project with respect to malaria vaccine development. PEPperPRINT’s peptide microarrays will be used to characterize the humoral immune response to MalVa’s novel malaria vaccine...

[more]

PEPperPRINT will join the 3rd Munich Biomarker Conference in Munich, Germany taking place November 26-27, 2013. We invite you to meet our representative Dr. Lisa Steinbrück in the Exhibition Area to learn more about...

[more]

We're pleased to launch the new PEPperCHIP® Oncovirus Epitope Microarray with 3,653 linear B-cell epitopes of...

[more]

PEPperPRINT is pleased to release two new application notes based on the PEPperCHIP® Peptide Microarray platform:

 

The application note "PEPperMAP® Type 1 Epitope Mapping of Mouse Monoclonal Antibody anti-HA (12CA5)"...

[more]

We're please to announce that PEPperPRINT will join the Medical Biodefense Conference 2013 in Munich, Germany taking place from on October 23-25, 2013. We invite you to meet our representative Dr. Lisa Steinbrück in the...

[more]

A video of PEPperPRINT's latest webinar is now available on YouTube and our own webinar page.

[more]

PEPperPRINT's unique peptide microarray platform is based on a completely new approach of combinatorial synthesis: Instead of using e.g. standard spotters or lithographic synthesis, amino acid micro particles are printed...

[more]

According to WHO, 49 laboratory-confirmed cases of human infection with novel Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported so far. Due to the severe acute respiratory disease of most...

[more]

PEPperPRINT is sponsoring the Deutsche Biotechnologietage 2013 taking place from May 14-15 in Stuttgart, Germany. We cordially invited to meet us at Booth 11 in the Exhibition Area to learn more on our new PEPperCHIP®...

[more]